Posts tagged “Quintiles”
Insiders and private equity backers of Quintiles sold nearly $95 million worth of stock in the company last week. So why are these sales happening now? WRALTechWire Insiders get the story.
Michael Mortimer, executive vice president and chief administration officer, at Quintiles has sold shares worth more than $8 million. He's the second senior executive officer to do so in the past week.
The world's largest lifer science company receives the top "Contract Research Organization" honor for the second consecutive year. Its Infosario Safety product wins the top honor for best technological development in clinical trials.
Quintiles executive John Ratliff is selling some of his stock in the biopharmaceutical services firm before he steps down at the end of the year. WRALTechWire Insiders can access the details.
In observation of World Diabetes Day on Thursday, made available a video, an informational graphic and a host of other information that - collectively that warns about the increasing threat posed by the disease worldwide. Affecting 366 million people worldwide, diabetes also accounts for a big percentage of healthcare costs. In 2011, the percentage was 11 percent. Dr. Erica Caveney of Quintiles discusses the state of the global fight - and what she feels is a bright future for diabetes patients.
Novella Clinical, a Quintiles acquisition focused on oncology and medical devices, has financial incentives to grow that business for its new parent. Learn how much of a payout Novella could earn.
BioAgilytix Labs, a fast-growing Durham laboratory providing contract testing for pharmaceutical, biotechnology and agricultural companies, has added new testing devices, more people, and is planning more space.
The world's largest life science services firm says business is looking good, but Wall Street turned sour on its stock. In its latest earnings report early Thursday, Quintiles increased its earnings forecast and says new business commitments are up 29 percent. However, revenue was flat in the just-completed quarter.
Several technology and life science firms with a major presence in North Carolina crack the top 25 in the annual World's Best Multinational Workplaces ranking. NetApp, Cisco, Google, Microsoft and Novartis all make the list.
Given the mammoth size of India's population, drug testing firms such as Quintiles have targeted the country for trials. But Quintiles, the world's largest life science services firm, has shut down an early-stage test group. As to why, the Durham-based company doesn't have much to say. The Supreme Court of India is up in arms about testing.
The MDA has struck an agreement with Quintiles, the world's largest life science services firm, to help the organization build a registry through which it hopes to advance the fight against muscular dystrophy and other diseases.
Quintiles (NYSE:Q) wants to find out if "pre-profiling" cancer patients to to get the genomic profile of tumors can help develop better, more targeted cancer therapies. Read more about a studt its doing with US Oncology Research.
The world's largest life science services firm is crunching big data in thousands of ways with the goal of helping clients develop and deliver drugs more quickly. It's also one of 12 winners in Computerworld's first "Data+ Editor's Choice Awards." To sweeten the honor, Q's data team is featured on the magazine's cover. In an exclusive interview, WRALTechWire talks with Q's CIO about the project, the importance of big, clean data, and the award.
"This is part of our strategic investment plan for the business in North America," a company spokesman says. "Cheminova's business in the region grew 23 percent in 2012, and has also shown positive growth thus far in 2013."
Quintiles CEO Tom Pike ventured into a Wall Street lion's den on Monday for a live interview with CNBC Mad Money host Jim Cramer. But rather than facing a mauling, Pike jousts in a friendly fashion with Cramer, who professes he likes the big "Q."
Quintiles' acquisition of Novella Clinical gives the CRO industry's largest player a missing piece. Executives from both companies discuss the deal in an exclusive for WRALTechWire Insiders.
Quintiles, the world's largest life science services firm, is growing even larger with the acquisition of a nearby competitor - Novella Clinical.
Don't be surprised if the big "Q" gets even bigger - soon. Wall Street loves Quintiles after a strong earnings report, and its stock price remains more than 10 percent above its May IPO price. Now the Durham-based life science services firm is looking to enhance its growth with more deals.